Eudaimonia Partners’s iShares MSCI USA Momentum Factor ETF MTUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,389
Closed -$473K 308
2023
Q3
$473K Sell
3,389
-67
-2% -$9.67K 0.11% 179
2023
Q2
$499K Sell
3,456
-13
-0.4% -$1.83K 0.11% 183
2023
Q1
$482K Sell
3,469
-1
-0% -$141 0.12% 181
2022
Q4
$506K Sell
3,470
-190
-5% -$27.6K 0.12% 175
2022
Q3
$480K Buy
+3,660
New +$513K 0.13% 169
2022
Q2
Sell
-4,092
Closed -$689K 420
2022
Q1
$689K Buy
+4,092
New +$673K 0.12% 200
2021
Q3
$2.1M Sell
11,989
-1,299
-10% -$231K 0.38% 78
2021
Q2
$2.31M Sell
13,288
-9,047
-41% -$1.53M 0.43% 62
2021
Q1
$3.59M Sell
22,335
-442
-2% -$73.1K 0.75% 27
2020
Q4
$3.67M Buy
22,777
+2,768
+14% +$424K 0.83% 19
2020
Q3
$2.95M Buy
20,009
+14,733
+279% +$2.11M 0.76% 26
2020
Q2
$691K Sell
5,276
-3,255
-38% -$394K 0.26% 95
2020
Q1
$908K Sell
8,531
-5,097
-37% -$630K 0.4% 65
2019
Q4
$1.71M Buy
+13,628
New +$1.65M 0.68% 34

Other funds holding MTUM

Eudaimonia Partners's MTUM Position: Q4 2023 in Review

Eudaimonia Partners sold out of iShares MSCI USA Momentum Factor ETF (MTUM) in Q4 2023, closing a stake of 3,389 shares — an estimated $473K sold.

Eudaimonia Partners first reported a position in MTUM in Q4 2019 and held it in 14 quarters. The position peaked at $3.67M in Q4 2020. 640 funds tracked by Wall St. Rank hold MTUM as of Q4 2023.

  • Eudaimonia Partners reported no remaining iShares MSCI USA Momentum Factor ETF position as of Q4 2023 after selling out during the quarter.
  • Eudaimonia Partners sold 3,389 iShares MSCI USA Momentum Factor ETF shares in Q4 2023, an estimated $473K.
  • Eudaimonia Partners first reported a position in iShares MSCI USA Momentum Factor ETF in Q4 2019 and held it in 14 quarters.
  • Eudaimonia Partners's iShares MSCI USA Momentum Factor ETF position peaked at $3.67M in Q4 2020.
  • 640 funds tracked by Wall St. Rank held iShares MSCI USA Momentum Factor ETF as of Q4 2023.

Based on Eudaimonia Partners's 13F filing for Q4 2023, filed 8 Feb 2024.